0001192482-19-000170.txt : 20190327
0001192482-19-000170.hdr.sgml : 20190327
20190327174436
ACCESSION NUMBER: 0001192482-19-000170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190327
DATE AS OF CHANGE: 20190327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajdler Arnaud
CENTRAL INDEX KEY: 0001293424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 19709287
MAIL ADDRESS:
STREET 1: ARPEGGIO ACQUISITION CORPORATION
STREET 2: 10 EAST 53RD STREET, 36TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-03-25
0001588972
Recro Pharma, Inc.
REPH
0001293424
Ajdler Arnaud
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Stock Option (right to buy)
6.41
2019-03-25
4
A
0
20000
0
A
2029-03-25
Common Stock
20000
20000
D
The option vests in three equal installments on March 25, 2020, 2021 and 2022.
/s/ Ryan Lake, Attorney-in-fact
2019-03-27